rs112082531
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_207122.2(EXT2):c.-31+474G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0277 in 1,535,772 control chromosomes in the GnomAD database, including 713 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.022 ( 50 hom., cov: 32)
Exomes 𝑓: 0.028 ( 663 hom. )
Consequence
EXT2
NM_207122.2 intron
NM_207122.2 intron
Scores
2
Splicing: ADA: 0.9939
1
1
Clinical Significance
Conservation
PhyloP100: 0.802
Publications
3 publications found
Genes affected
EXT2 (HGNC:3513): (exostosin glycosyltransferase 2) This gene encodes one of two glycosyltransferases involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type II form of multiple exostoses. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
EXT2 Gene-Disease associations (from GenCC):
- exostoses, multiple, type 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P
- seizures-scoliosis-macrocephaly syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- hereditary multiple osteochondromasInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 11-44096326-G-A is Benign according to our data. Variant chr11-44096326-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1182129.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0217 (3300/152270) while in subpopulation NFE AF = 0.0322 (2189/68010). AF 95% confidence interval is 0.0311. There are 50 homozygotes in GnomAd4. There are 1574 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 50 AD,AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0217 AC: 3297AN: 152152Hom.: 50 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3297
AN:
152152
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0205 AC: 2801AN: 136450 AF XY: 0.0207 show subpopulations
GnomAD2 exomes
AF:
AC:
2801
AN:
136450
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0283 AC: 39167AN: 1383502Hom.: 663 Cov.: 32 AF XY: 0.0279 AC XY: 19020AN XY: 682722 show subpopulations
GnomAD4 exome
AF:
AC:
39167
AN:
1383502
Hom.:
Cov.:
32
AF XY:
AC XY:
19020
AN XY:
682722
show subpopulations
African (AFR)
AF:
AC:
213
AN:
31584
American (AMR)
AF:
AC:
492
AN:
35698
Ashkenazi Jewish (ASJ)
AF:
AC:
521
AN:
25168
East Asian (EAS)
AF:
AC:
1
AN:
35724
South Asian (SAS)
AF:
AC:
617
AN:
79216
European-Finnish (FIN)
AF:
AC:
1114
AN:
33910
Middle Eastern (MID)
AF:
AC:
168
AN:
5632
European-Non Finnish (NFE)
AF:
AC:
34401
AN:
1078684
Other (OTH)
AF:
AC:
1640
AN:
57886
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
1822
3643
5465
7286
9108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0217 AC: 3300AN: 152270Hom.: 50 Cov.: 32 AF XY: 0.0211 AC XY: 1574AN XY: 74454 show subpopulations
GnomAD4 genome
AF:
AC:
3300
AN:
152270
Hom.:
Cov.:
32
AF XY:
AC XY:
1574
AN XY:
74454
show subpopulations
African (AFR)
AF:
AC:
280
AN:
41554
American (AMR)
AF:
AC:
255
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
84
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5166
South Asian (SAS)
AF:
AC:
26
AN:
4820
European-Finnish (FIN)
AF:
AC:
360
AN:
10620
Middle Eastern (MID)
AF:
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2189
AN:
68010
Other (OTH)
AF:
AC:
52
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
158
316
474
632
790
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Sep 06, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.